Artelo Biosciences Faces Nasdaq Compliance Challenge, Must Meet $2.5M Equity Requirement by July 7

Artelo Biosciences has received a Nasdaq notice for non-compliance with the minimum stockholders' equity requirement of $2.5mln. The company has until July 7, 2025, to submit a compliance plan and potentially until November 18, 2025, to meet the requirements. Artelo is exploring options to address the deficiency but faces uncertainty regarding the acceptance of its compliance plan and the potential success of any appeals against delisting.